FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2070469501> ?p ?o ?g. }

• W2070469501 endingPage "1101" @default.
• W2070469501 startingPage "1089" @default.
• W2070469501 abstract "Can gonadotrophin-releasing hormone agonists (GnRH-a) preserve long-term fertility when administered prior to and concomitantly with chemotherapy? GnRH-a display a differential protective effect on fertility, depending upon the specific chemotherapy-induced mechanism of ovarian injury. The role of GnRH-a in fertility preservation has been constantly debated and their use is considered experimental due to conflicting clinical evidence and paucity of data regarding their mechanism for ovarian protection. In vivo model: 7–8 weeks old imprinting control region (ICR) mice were injected with GnRH-a (Leuprolide-acetate) or saline prior to and concomitantly with cyclophosphamide, doxorubicin or saline and sacrificed at various time-points on a longitudinal follow-up; 24 h (n = 36), 1 week (n = 40), 1 month (n = 36) and 9 months (n = 66) post chemotherapy treatment. Blood samples were drawn on Day 0 and on a monthly basis after chemotherapy treatment. On the day of sacrifice, blood samples were drawn and ovaries excised and processed for either immunohistochemistry (IHC), protein or RNA extraction. In vitro model: 21–23 days old Wistar-derived rats were sacrificed, their ovaries excised and primary granulosa cells (PGC) were either isolated for in vitro culture, or processed for immunofluorescence (IF) as well as for protein or RNA extraction. Ovarian reserve was estimated by serial measurements of serum anti-mullerian hormone (AMH), quantified by the AMH Gen II ELISA assay. Ovarian AMH and phosphorylated Akt (pAkt) were detected by immunoblotting. Vascular endothelial growth factor (VEGF) was measured by quantitative PCR. Ovarian GnRH receptor (GnRHR), AMH and CD34 were visualized by IHC, and apoptosis was evaluated using TdT (terminal deoxynucleotidyl transferase)-mediated dUDP nick-end labeling (TUNEL). Cyclophosphamide-induced ovarian injury caused a prompt decrease in AMH level (P < 0.01) and a further long-term decline in serum AMH (P = 0.017), indicating damage to the ovarian reserve. Pretreatment with GnRH-a diminished AMH-decrease (P < 0.05) and maintained serum AMH level in the long run (P < 0.05). Doxorubicin-exerted ovarian-vascular-injury is also displayed by an acute increase in ovarian VEGF level (P < 0.05) and a sustained decrease in serum AMH level (P < 0.001). This was followed by ovarian recovery manifested by increased neovascularization. GnRH-a delayed the recovery in AMH level and decreased the level of VEGF (P < 0.001), thus interfering with the vascular recovery subsequent to doxorubicin-induced vascular damage. To portray the differential mechanism of each chemotherapy, cyclophosphamide and doxorubicin were given separately, whereas most of the clinical protocols include several types of chemotherapies. Thus, future study should explore a prospective evaluation of various chemotherapies, as well as combined chemotherapeutic protocols. Our study demonstrates that different chemotherapy agents affect the ovary via diverse mechanisms and thus the administration of GnRH-a concomitantly, could be beneficial to a subpopulation of patients treated with cyclophosphamide-based protocols. This work was partially supported by a grant from the Israel Science Foundation (ISF) to I.B.-A. The authors have no conflict of interest to disclose." @default.
• W2070469501 created "2016-06-24" @default.
• W2070469501 creator A5007458418 @default.
• W2070469501 creator A5012814827 @default.
• W2070469501 creator A5034523621 @default.
• W2070469501 creator A5046141076 @default.
• W2070469501 creator A5058873836 @default.
• W2070469501 creator A5077499704 @default.
• W2070469501 creator A5082961156 @default.
• W2070469501 creator A5084991433 @default.
• W2070469501 date "2015-03-21" @default.
• W2070469501 modified "2023-10-18" @default.
• W2070469501 title "Gonadotrophin-releasing hormone agonists for fertility preservation: unraveling the enigma?" @default.
• W2070469501 cites W1491484517 @default.
• W2070469501 cites W1968088508 @default.
• W2070469501 cites W1971420972 @default.
• W2070469501 cites W1973252291 @default.
• W2070469501 cites W1973522194 @default.
• W2070469501 cites W1986094390 @default.
• W2070469501 cites W1988282054 @default.
• W2070469501 cites W1990723309 @default.
• W2070469501 cites W1995380492 @default.
• W2070469501 cites W2003583785 @default.
• W2070469501 cites W2007653357 @default.
• W2070469501 cites W2008973301 @default.
• W2070469501 cites W2009207386 @default.
• W2070469501 cites W2010303851 @default.
• W2070469501 cites W2019552711 @default.
• W2070469501 cites W2020391016 @default.
• W2070469501 cites W2021403521 @default.
• W2070469501 cites W2022109629 @default.
• W2070469501 cites W2025786012 @default.
• W2070469501 cites W2028973767 @default.
• W2070469501 cites W2034172400 @default.
• W2070469501 cites W2042368058 @default.
• W2070469501 cites W2050875469 @default.
• W2070469501 cites W2051526299 @default.
• W2070469501 cites W2061215876 @default.
• W2070469501 cites W2080669943 @default.
• W2070469501 cites W2082621216 @default.
• W2070469501 cites W2089454642 @default.
• W2070469501 cites W2097206260 @default.
• W2070469501 cites W2097357893 @default.
• W2070469501 cites W2097540678 @default.
• W2070469501 cites W2099615704 @default.
• W2070469501 cites W2101407679 @default.
• W2070469501 cites W2103453132 @default.
• W2070469501 cites W2108119810 @default.
• W2070469501 cites W2109166024 @default.
• W2070469501 cites W2111770224 @default.
• W2070469501 cites W2117722296 @default.
• W2070469501 cites W2123533470 @default.
• W2070469501 cites W2123790399 @default.
• W2070469501 cites W2123840670 @default.
• W2070469501 cites W2125564527 @default.
• W2070469501 cites W2128780026 @default.
• W2070469501 cites W2132421508 @default.
• W2070469501 cites W2135215861 @default.
• W2070469501 cites W2136159364 @default.
• W2070469501 cites W2136336924 @default.
• W2070469501 cites W2139473755 @default.
• W2070469501 cites W2139777504 @default.
• W2070469501 cites W2141153820 @default.
• W2070469501 cites W2148070806 @default.
• W2070469501 cites W2154559552 @default.
• W2070469501 cites W2162162332 @default.
• W2070469501 cites W2165533385 @default.
• W2070469501 cites W2167038118 @default.
• W2070469501 cites W2167165624 @default.
• W2070469501 cites W2169915553 @default.
• W2070469501 cites W2252647763 @default.
• W2070469501 cites W2335138225 @default.
• W2070469501 doi "https://doi.org/10.1093/humrep/dev037" @default.
• W2070469501 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25796551" @default.
• W2070469501 hasPublicationYear "2015" @default.
• W2070469501 type Work @default.
• W2070469501 sameAs 2070469501 @default.
• W2070469501 citedByCount "37" @default.
• W2070469501 countsByYear W20704695012015 @default.
• W2070469501 countsByYear W20704695012016 @default.
• W2070469501 countsByYear W20704695012017 @default.
• W2070469501 countsByYear W20704695012018 @default.
• W2070469501 countsByYear W20704695012019 @default.
• W2070469501 countsByYear W20704695012020 @default.
• W2070469501 countsByYear W20704695012021 @default.
• W2070469501 countsByYear W20704695012022 @default.
• W2070469501 countsByYear W20704695012023 @default.
• W2070469501 crossrefType "journal-article" @default.
• W2070469501 hasAuthorship W2070469501A5007458418 @default.
• W2070469501 hasAuthorship W2070469501A5012814827 @default.
• W2070469501 hasAuthorship W2070469501A5034523621 @default.
• W2070469501 hasAuthorship W2070469501A5046141076 @default.
• W2070469501 hasAuthorship W2070469501A5058873836 @default.
• W2070469501 hasAuthorship W2070469501A5077499704 @default.
• W2070469501 hasAuthorship W2070469501A5082961156 @default.
• W2070469501 hasAuthorship W2070469501A5084991433 @default.
• W2070469501 hasBestOaLocation W20704695011 @default.
• W2070469501 hasConcept C126322002 @default.

• next